Solana Company
HealthcareNASDAQ:HSDT · NASDAQ Capital Market
+$0.03 today
Vol 0.38M · Avg 0.36M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
-13.6%
avg 3713.6%
ROIC
-7.0%
avg -5052.6%
ROA
-13.5%
avg -224.9%
Analysis
ROIC is currently the strongest return metric at -7.0% versus its period average of -5052.6%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Dane Carl Andreeff | President, Chief Executive Officer & Director | $1.49M | — | 60 | $52,400.00 | 0.09% |
Jeffrey S. Mathiesen | Chief Financial Officer, Treasurer & Secretary | $1.16M | — | 65 | $26,200.00 | 0.04% |
Antonella Favit-Van Pelt | Chief Medical Officer | $521,386.00 | — | 59 | $17,500.00 | 0.03% |
Choon Wee Chee | Executive Chairman | $305,686.00 | — | 54 | $0.00 | <0.01% |
Agustina Gani Tjandrasuwita | COO & Deputy CFO | — | — | 50 | $0.00 | <0.01% |
Lawrence Picciano | Senior Vice President of Engineering, Quality & Regulatory Affairs | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
No insider transactions in the last 12 months.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | N/A | N/A1 analysts |
| Net Income | N/A | N/A | N/A | N/A1 analysts |
| EBIT | N/A | N/A | N/A | N/A1 analysts |
Analysis
Analysis will appear once historical growth or forward estimates are available for this company.
Competitors
Peer companies in the same sector
Electromed, Inc.
AMEX:ELMD
$307.52M
Perspective Therapeutics, Inc.
AMEX:CATX
$227.89M
Profound Medical Corp.
NASDAQ:PROF
$200.47M
InfuSystem Holdings, Inc.
AMEX:INFU
$184.46M
Inogen, Inc.
NASDAQ:INGN
$173.28M
Quanterix Corporation
NASDAQ:QTRX
$146.03M
TriSalus Life Sciences, Inc.
NASDAQ:TLSI
$142.92M
SANUWAVE Health, Inc.
NASDAQ:SNWV
$128.21M
Nano-X Imaging Ltd.
NASDAQ:NNOX
$122.48M
Outset Medical, Inc.
NASDAQ:OM
$83.23M
Who manages HSDT?
Solana Company (HSDT) lists 6 active executives. The top listed executive is Antonella Favit-Van Pelt, Chief Medical Officer.
Are HSDT insiders buying or selling?
Recent insider activity shows net buying of $15.93M.
Explore More
Continue the stock analysis
Jump to another research area for this company.